Holen Sie sich die Stockscreener-App
4.02
3.13%
-0.13
Handel nachbörslich:
4.07
0.05
+1.24%
Schlusskurs vom Vortag:
$4.15
Offen:
$4.07
24-Stunden-Volumen:
49,484
Relative Volume:
0.68
Marktkapitalisierung:
$6.37M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.58M
KGV:
-3.4957
EPS:
-1.15
Netto-Cashflow:
$-9.80M
1W Leistung:
-7.37%
1M Leistung:
-24.26%
6M Leistung:
-52.76%
1J Leistung:
-89.25%
1-Tages-Spanne:
$3.97
$4.12
1-Wochen-Bereich:
$3.90
$4.81
52-Wochen-Spanne:
$3.80
$44.00
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
Firmenname
Acurx Pharmaceuticals Inc
Sektor
Branche
Telefon
917-533-1469
Adresse
259 LIBERTY AVENUE, STATEN ISLAND
Vergleichen Sie ACXP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
4.02 | 6.58M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Acurx Pharmaceuticals Inc Aktie (ACXP) Neueste Nachrichten
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events - Shreveport Times
What machine learning models say about Acurx Pharmaceuticals Inc.Dip Buying & Verified Swing Trading Watchlist - newser.com
Acurx Pharmaceuticals Increases Authorized Common Stock Shares - TipRanks
Will breakout in Acurx Pharmaceuticals Inc. lead to full recoveryTrade Ideas & Weekly High Momentum Picks - newser.com
Acurx Pharmaceuticals Inc. stock trendline breakdownJuly 2025 Rallies & Long Hold Capital Preservation Plans - newser.com
What MACD and RSI say about Acurx Pharmaceuticals Inc.Weekly Trend Report & Technical Entry and Exit Tips - newser.com
Acurx Pharmaceuticals (NASDAQ:ACXP) Upgraded to Hold at Wall Street Zen - Defense World
Is Acurx Pharmaceuticals Inc. in accumulation or distribution phaseTrade Entry Report & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Understanding Acurx Pharmaceuticals Inc.’s price movementWall Street Watch & Free Community Supported Trade Ideas - newser.com
Acurx Pharmaceuticals Inc. stock volume spike explainedJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - newser.com
Is Acurx Pharmaceuticals Inc stock technically oversoldShare Buyback & Weekly High Return Stock Forecasts - خودرو بانک
Bearish Setup: What is Acurx Pharmaceuticals Incs 5 year growth outlookRecession Risk & Real-Time Volume Triggers - خودرو بانک
Published on: 2025-09-20 01:31:00 - newser.com
Risk Hedge: Is Acurx Pharmaceuticals Inc a strong growth stockNew Guidance & Daily Chart Pattern Signal Reports - خودرو بانک
Acurx Pharmaceuticals shareholders approve warrant exercise and share increase - Investing.com
Using data filters to optimize entry into Acurx Pharmaceuticals Inc.2025 Fundamental Recap & Risk Controlled Stock Alerts - newser.com
Acurx Pharmaceuticals Shareholders Approve Key Issuance Plans - TipRanks
Best data tools to analyze Acurx Pharmaceuticals Inc. stockJuly 2025 Trade Ideas & Daily Technical Forecast Reports - newser.com
Using Bollinger Bands to evaluate Acurx Pharmaceuticals Inc.2025 Market WrapUp & Precise Buy Zone Identification - newser.com
Published on: 2025-09-19 13:22:33 - newser.com
Acurx Pharmaceuticals Inc. stock chart pattern explainedGap Up & Community Consensus Stock Picks - newser.com
Aug Catalysts: What is the dividend yield of Acurx Pharmaceuticals IncWeekly Investment Summary & Expert Approved Momentum Trade Ideas - خودرو بانک
What to expect from Acurx Pharmaceuticals Inc. in the next 30 daysMarket Trend Summary & Reliable Entry Point Trade Alerts - newser.com
Applying Wyckoff theory to Acurx Pharmaceuticals Inc. stockFed Meeting & Real-Time Chart Pattern Alerts - newser.com
Acurx Pharmaceuticals Inc. stock trend outlook and recovery path2025 Macro Impact & Low Drawdown Momentum Ideas - newser.com
What recovery options are there for Acurx Pharmaceuticals Inc.2025 Price Targets & Precise Trade Entry Recommendations - newser.com
How to build a dashboard for Acurx Pharmaceuticals Inc. stockQuarterly Profit Review & Risk Adjusted Buy and Sell Alerts - newser.com
Chart overlay techniques for tracking Acurx Pharmaceuticals Inc.Portfolio Gains Report & Daily Technical Stock Forecast Reports - newser.com
Risk Recap: What is Meritage Homes Corporation s 5 year growth outlookWeekly Profit Recap & Safe Capital Growth Tips - خودرو بانک
Live market analysis of Serina Therapeutics Inc.July 2025 News Drivers & Fast Entry Momentum Alerts - newser.com
Aug Rallies: What are the risks of holding Acurx Pharmaceuticals IncJuly 2025 Highlights & Detailed Earnings Play Alerts - خودرو بانک
Bull Bear: Can Acurx Pharmaceuticals Inc keep up with sector leadersWeekly Investment Summary & Technical Pattern Alert System - خودرو بانک
Treasury Yields: How do insiders feel about USB.PRQEarnings Risk Summary & Reliable Volume Spike Alerts - خودرو بانک
Bull Bear: Will Acurx Pharmaceuticals Inc. outperform the market in YEARWeekly Trend Report & Real-Time Price Movement Reports - خودرو بانک
Aug PreEarnings: What is the dividend yield of Acurx Pharmaceuticals IncQuarterly Investment Review & AI Powered Buy and Sell Recommendations - خودرو بانک
Finanzdaten der Acurx Pharmaceuticals Inc-Aktie (ACXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Acurx Pharmaceuticals Inc-Aktie (ACXP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Sailer Carl | Director |
Jan 06 '25 |
Buy |
1.01 |
24,631 |
25,000 |
137,183 |
| LUCI DAVID P | President and CEO |
Jan 06 '25 |
Buy |
1.01 |
49,261 |
50,000 |
1,097,458 |
| Donohue James J. | Director |
Jan 06 '25 |
Buy |
1.01 |
9,852 |
10,000 |
22,352 |
| DELUCCIA ROBERT J | Director |
Jan 06 '25 |
Buy |
1.01 |
49,261 |
50,000 |
1,010,196 |
| DEAN JACK H | Director |
Jan 06 '25 |
Buy |
1.01 |
9,852 |
10,000 |
21,776 |
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):